- •Preface
- •Contents
- •Pattern Approach for Lung Imaging
- •1: Nodule
- •Solitary Pulmonary Nodule (SPN), Solid
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Lung Cancer (Solid Adenocarcinoma)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Carcinoid or Atypical Carcinoid
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •BALT Lymphoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Tuberculoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Hamartoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Sclerosing Hemangioma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Ground-Glass Opacity Nodule
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Atypical Adenomatous Hyperplasia (AAH)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Adenocarcinoma in Situ (AIS)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Minimally Invasive Adenocarcinoma (MIA)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •2: Mass
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Sarcoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Progressive Massive Fibrosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Actinomycosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •3: Consolidation
- •Lobar Consolidation
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Lobar Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Invasive Mucinous Adenocarcinoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Infarction
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Patchy and Nodular Consolidation
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Airway-Invasive Pulmonary Aspergillosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Cryptococcosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •IgG4-Related Lung Disease
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lymphomatoid Granulomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •4: Beaded Septum Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •References
- •5: Comet Tail Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Rounded Atelectasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •6: CT Halo Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Angioinvasive Pulmonary Aspergillosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Metastatic Hemorrhagic Tumors
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Endometriosis with Catamenial Hemorrhage
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •7: Galaxy Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Galaxy Sign in Pulmonary Tuberculosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •8: Reversed Halo Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Mucormycosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lymphomatoid Granulomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •9: Tree-in-Bud Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Aspiration Bronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Foreign-Body-Induced Pulmonary Vasculitis (Cellulose and Talc Granulomatosis)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Bronchial Atresia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Bronchial Tuberculosis and Mucoid Impaction
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Foreign-Body Aspiration
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Allergic Bronchopulmonary Aspergillosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •11: Lobar Atelectasis Sign
- •Disease Causing the Sign
- •Distribution
- •Clinical Considerations
- •Right Upper Lobar Atelectasis
- •Left Upper Lobar Atelectasis
- •Right Middle Lobar Atelectasis
- •Lower Lobar Atelectasis
- •References
- •Cavity
- •Diseases Causing the Cavity
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Langerhans Cell Histiocytosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Septic Pulmonary Embolism
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Cavitary Pulmonary Tuberculosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Paragonimiasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Cyst
- •Diseases Causing the Cyst
- •Distribution
- •Clinical Considerations
- •Blebs and Bullae
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Sequestration
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Intrapulmonary Bronchogenic Cyst
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Traumatic Lung Cysts
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •References
- •Mosaic Attenuation
- •Diseases Causing the Mosaic Attenuation Pattern
- •Distribution
- •Clinical Considerations
- •Cystic Fibrosis
- •Pathology and Pathogenesis
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Constrictive Bronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Chronic Pulmonary Thromboembolism
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Idiopathic Pulmonary Arterial Hypertension
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Airway Disease (Bronchiectasis and Bronchiolectasis)
- •Distribution
- •Clinical Considerations
- •Swyer-James-MacLeod Syndrome
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Dyskinetic Cilia Syndrome
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •14: Air-Crescent Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Aspergilloma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Rasmussen’s Aneurysm
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •15: Signet Ring Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •16: Interlobular Septal Thickening
- •Smooth Septal Thickening
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Edema
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Niemann–Pick Disease
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Nodular Septal Thickening
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Lymphangitic Carcinomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •References
- •17: Honeycombing
- •Honeycombing with Subpleural or Basal Predominance
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Asbestosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Honeycombing with Upper Lung Zone Predominance
- •Diseases Causing the Pattern and Distribution
- •Distribution
- •Clinical Considerations
- •Idiopathic Familial Pulmonary Fibrosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Chronic Hypersensitivity Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •End-stage Fibrotic Pulmonary Sarcoidosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •18: Small Nodules
- •Small Nodules with Centrilobular Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Mycoplasma Pneumoniae Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diffuse Panbronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Follicular Bronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Tumor Embolism
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pneumoconiosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Sarcoidosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Alveoloseptal Amyloidosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Small Nodules with Random (Miliary) Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Miliary Tuberculosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Miliary Metastasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •19: Multiple Nodular or Mass(-like) Pattern
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Metastasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Lymphoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Amyloidomas
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •ANCA-Associated Granulomatous Vasculitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Ground-Glass Opacity with Reticulation and Fibrosis
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Ground-Glass Opacity with Reticulation, but without Fibrosis (Crazy-Paving Appearance)
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pneumocystis jirovecii Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lipoid Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Alveolar Proteinosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Mucinous Adenocarcinoma or Adenocarcinoma in Situ, Diffuse Form
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Desquamative Interstitial Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Ground-Glass Opacity without Reticulation, with Small Nodules
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Subacute Hypersensitivity Pneumonitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Cytomegalovirus Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diffuse Alveolar Hemorrhage
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Ground-Glass Opacity without Reticulation, Diffuse Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Acute Hypersensitivity Pneumonitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Acute Eosinophilic Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •22: Consolidation
- •Consolidation with Subpleural or Patchy Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Cryptogenic Organizing Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Chronic Eosinophilic Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Churg–Strauss Syndrome
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Radiation Pneumonitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Consolidation with Diffuse Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Viral Pneumonias
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Acute Interstitial Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diffuse Alveolar Hemorrhage
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •23: Decreased Opacity with Cystic Walls
- •Cavities
- •Diseases Causing Cavities
- •Distribution
- •Clinical Considerations
- •Rheumatoid Lung Nodules
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Cavitary Metastasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Cysts
- •Diseases Causing Multiple Cysts
- •Distribution
- •Clinical Considerations
- •Lymphangioleiomyomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lymphocytic Interstitial Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Emphysema
- •Distribution
- •Clinical Considerations
- •Centrilobular Emphysema
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •Patient Prognosis
- •Paraseptal Emphysema
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •Patient Prognosis
- •References
- •24: Decreased Opacity without Cystic Walls
- •Mosaic Attenuation, Vascular
- •Distribution
- •Clinical Considerations
- •Airway Diseases Causing Mosaic Attenuation
- •Distribution
- •Clinical Considerations
- •Asthma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Distribution
- •Clinical Considerations
- •Cystic Fibrosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •26: Pneumonia
- •Lobar Pneumonia
- •Bronchopneumonia
- •Interstitial Pneumonia
- •27: Drug-Induced Lung Disease
- •Interstitial Pneumonitis and Fibrosis
- •Eosinophilic Pneumonia
- •Cryptogenic Organizing Pneumonia
- •Diffuse Alveolar Damage
- •Hypersensitivity Pneumonia
- •References
- •Systemic Lupus Erythematosus (SLE)
- •Rheumatoid Arthritis (RA)
- •Progressive Systemic Sclerosis (PSS)
- •Sjögren’s Syndrome
- •Mixed Connective Tissue Disease
- •Ankylosing Spondylitis
- •References
Interstitial Pneumonia |
265 |
|
|
Interstitial Pneumonia
Interstitial pneumonia is characterized histologically by a mononuclear inßammatory cell inÞltrate in the alveolar septa and interstitial tissue surrounding small parenchymal vessels (Figs. 26.7 and 26.8). The most common causes are
Mycoplasma pneumoniae, viruses, and Pneumocystis jiroveci. Because Mycoplasma pneumoniae pneumonia and
Pneumocystis pneumonia were described in other chapters, focused descriptions on viral pneumonias are rendered in this chapter.
The following are common pathologic Þndings in viral pneumonia: viruses can result in several pathologic forms of lower respiratory tract infection including tracheobronchitis,
a
c
cellular bronchiolitis, and pneumonia. Because viral organisms replicate within tissue cells, the most prominent histologic changes are observed in the epithelium and adjacent interstitium. In tracheobronchitis, airway walls are congested and lumen contains mononuclear cell inÞltrates. Degeneration and desquamation of the epithelial cells are seen. Cellular bronchiolitis, particularly important in children, appears with epithelial necrosis, neutrophilic exudate in the airway lumen, and predominantly mononuclear inÞltrates in its wall. Parenchymal involvement, the pneumonia, starts with the involvement of the lung adjacent to the terminal and respiratory bronchioles; however, extension throughout the lobule may occur (Fig. 26.7). Rapidly progressive pneumonia may occur particularly in the elderly and in
b
d
Fig. 26.7 Cytomegalovirus pneumonia over a follow-up period of 3 weeks in a 68-year-old woman with diffuse large B-cell lymphoma. (aÐc) Lung window images of CT scans (2.5-mm section thickness) obtained at levels of distal main bronchi (a), right inferior pulmonary vein (b), and cardiac ventricles (c), respectively, show bilateral bronchopneumonia pattern of lung abnormality comprising parenchymal opacity (arrows), tree-in-bud patterns (arrowheads), and variable-sized nodules (open arrows). (d) High-magniÞcation photomicrograph of
pathologic specimen obtained with transbronchial lung biopsy from left lower lobe discloses diffuse alveolar damage with Þbrinous exudate and interstitial Þbroblastic proliferation. Note suspicious viral inclusion (arrows) in atypical pneumocytes. (e) High-magniÞcation (×400) photomicrograph reveals a pneumocyte harboring intranuclear large viral inclusion (arrow), which is single, basophilic, and round to oval with peripheral halo. Inset: immunohistochemical staining (ABC methods, ×200) for cytomegalovirus showing many infected pneumocytes
266 |
26 Pneumonia |
|
|
e
Fig. 26.7 (continued)
a
c
immunocompromised patients where the lungs histologically show diffuse alveolar damage comprising interstitial lymphocyte inÞltration, airspace hemorrhage, edema and Þbrin, type 2 cell hyperplasia, and hyaline membrane formation [5] (Figs. 26.7 and 26.8).
Viral pneumonia manifest radiologically as poorly deÞned nodules (airspace nodules of 4Ð10 mm in diameter) and patchy areas of peribronchial GGO and airspace consolidation. Because of the associated cellular bronchiolitis, hyperinßation is commonly present [5Ð7]. Progressive pneumonia shows the rapid conßuence of consolidation leading to diffuse alveolar damage, consisting of homogeneous or patchy unilateral or bilateral airspace consolidation and GGO or poorly deÞned small centrilobular nodules [5] (Figs. 26.7 and 26.8).
CT parenchymal lung abnormalities may be classiÞed into three main patterns according to the distribution and patterns of
b
d
Fig. 26.8 Adenovirus pneumonia in a 35-year-old woman with nonHodgkinÕs lymphoma who underwent hematopoietic stem cell transplantation 1 year ago. (a, b) Lung window images of thin-section (1.0-mm section thickness) CT scan obtained at levels of great vessels (a) and right inferior pulmonary vein (b), respectively, show extensive and patchy areas of ground-glass opacity (arrows) associated with interlobular septal thickening (arrowheads) and intralobular reticulation, forming so-called crazy-paving appearance in both lungs. (c) High-magniÞcation photomicrograph obtained with surgical lung
biopsy from left lower lobe displays intra-alveolar Þbrinous exudate forming hyaline membrane (arrows) and interstitial Þbroblastic proliferation (arrowheads) suggestive of mixed exudative and proliferative phase of diffuse alveolar damage (Reprinted from [11] with permission) (d) Photomicrographs of pathologic specimen (left, ×1,000) and after immunohistochemical staining for adenovirus (right, ×100) show alveolar lining cells with intranuclear inclusions (arrows, left) and poorly demarcated smudges (arrowheads, right) within nucleus, indicating positivity for adenovirus infection
Interstitial Pneumonia |
267 |
|
|
a |
a |
b
b
Fig. 26.9 Inßuenza A (H1N1) pneumonia showing bronchopneumonia pattern in a 68-year-old woman with previous aortic valve replacement. (a) Lung window image of CT scan (2.5-mm section thickness) obtained at level of right bronchus intermedius shows multifocal areas of tree-in-bud signs (arrows) and lobular consolidation or poorly deÞned nodules (open arrows) in both lungs. Enlarged calciÞed and ruptured lymph nodes were seen in the bilateral hila and mediastina, indicating possible anthracoÞbrosis of airways on mediastinal window image. (b) CT scan obtained at level of right middle lobar bronchus demonstrates multifocal areas of tree-in-bud sign (arrows) and lobular area of ground-glass opacity (open arrow) in both lungs (Reprinted from Kang et al. [8] with permission)
Fig. 26.10 Inßuenza A (H1N1) pneumonia showing cryptogenic organizing pneumonia pattern in a 66-year-old man. (a) Lung window image of CT scan (2.5-mm section thickness) obtained at level of right upper lobar bronchus shows patchy areas of ground-glass opacity distributed mainly along bronchovascular bundles in both lungs. (b) Coronal reformatted (2.0-mm section thickness) CT scan also demonstrates parenchymal opacity lesions distributed along bronchovascular bundles (arrows) or subpleural (open arrows) lungs (Reprinted from Kang et al. [8] with permission)
the lung abnormalities: cryptogenic organizing pneumonia (COP), acute interstitial pneumonia (AIP), and bilateral extensive bronchopneumonia (Figs. 26.9, 26.10, and 26.11). This classiÞcation may help stratify patients with viral pneumonia in terms of their prognoses. In a particular viral pneumonia (inßuenza A [H1N1] pneumonia), patients with bronchopneumonia pattern have a tendency to belong to the mild illness group, whereas patients with AIP pattern show more severe clinical course in their outcome [8]. According to one study, CT Þndings in patients having a mild pneumonia course consist mainly of inßammatory lesions involving large or small airways with focal centrilobular small nodules with tree-in-bud sign and bronchiolar wall thickening [9]. Fatal cases of the same pneumonia present as areas of consolidation with or
without GGO on CT scans (AIP pattern) and the abnormalities are pathologically correlated with diffuse alveolar damage [10]. Therefore, it seems that pattern and extent of lung lesions observed at CT in viral pneumonias may be a determining factor for predicting patientÕs clinical course and prognosis [8].
The radiologic Þndings of adult viral pneumonias are variable and overlapping (Table 26.1). SpeciÞc organism diagnosis of a viral pneumonia cannot be made on the basis of imaging features alone. Clinical features such as patient age, immune status, time of year, illness in other family members, community outbreaks, onset, severity, duration of symptoms, and the presence of a rash remain as important aids in diagnosing viral causes of both atypical pneumonia and pneumonia in immunocompromised patients [5].
268 |
26 Pneumonia |
|
|
a |
b |
Fig. 26.11 Inßuenza A (H1N1) pneumonia showing acute interstitial pneumonia pattern in a 58-year-old woman with multiple myeloma. (a, b) Lung window images of CT scan (2.5-mm section thickness) obtained at level of right upper lobar bronchus (a) and lower lobar bronchi (b), respectively, show patchy and extensive parenchymal opacity
lesions without speciÞc zonal predominance in both lungs. Additionally, traction bronchiectasis is noted in right upper lobe, suggesting proliferative phase of diffuse alveolar damage. Lesions progressed on followup chest radiographs and patient died of the disease in following 6 days (Reprinted from Kang et al. [8] with permission)
Table 26.1 Summary of CT Þndings in viral pneumonias
|
|
GGO with lobular |
|
Thickened |
|
|
Centrilobular nodules |
distribution |
Segmental consolidation |
interlobular septa |
Diffuse GGO |
Inßuenza |
+++ |
+++ |
|
|
+ |
Measles |
++ |
+ |
+ |
+ |
+ |
Hantavirus |
|
|
++ |
+ |
+++ |
|
|
|
|||
Adenovirus |
++ |
+ |
+++ |
|
|
HSV |
+ |
+++ |
+++ |
|
+ |
VZV |
+++ |
+ |
|
|
|
CMV |
++ |
++ |
+ |
+ |
++ |
EBV |
+ |
+ |
+ |
|
+ |
Reprinted from Kim et al. [5] with permission
Note: HSV herpes simplex virus, VZV varicella-zoster virus, CMV cytomegalovirus, EBV EpsteinÐBarr virus, GGO ground-glass opacity
Referen ces
1. Tanaka N, Matsumoto T, Kuramitsu T, et al. High resolution CT Þndings in community-acquired pneumonia. J Comput Assist Tomogr. 1996;20:600Ð8.
2. Lee JY, Lee KS, Jung KJ, et al. Pulmonary tuberculosis: CT and pathologic correlation. J Comput Assist Tomogr. 2000;24:691Ð8.
3. Ikezoe J, Takeuchi N, Johkoh T, et al. CT appearance of pulmonary tuberculosis in diabetic and immunocompromised patients: comparison with patients who had no underlying disease. AJR Am J Roentgenol. 1992;159:1175Ð9.
4.Reittner P, Muller NL, Heyneman L, et al. Mycoplasma pneumoniae pneumonia: radiographic and high-resolution CT features
in 28 patients. AJR Am J Roentgenol. 2000;174:37Ð41.
5. Kim EA, Lee KS, Primack SL, et al. Viral pneumonias in adults: radiologic and pathologic Þndings. Radiographics. 2002;22(Spec No):S137Ð49.
6. Han BK, Son JA, Yoon HK, Lee SI. Epidemic adenoviral lower respiratory tract infection in pediatric patients: radiographic and clinical characteristics. AJR Am J Roentgenol. 1998;170:1077Ð80.
7. Moon JH, Kim EA, Lee KS, Kim TS, Jung KJ, Song JH. Cytomegalovirus pneumonia: high-resolution CT Þndings in ten non-AIDS immunocompromised patients. Korean J Radiol. 2000;1:73Ð8.
8. Kang H, Lee KS, Jeong YJ, Lee HY, Kim KI, Nam KJ. Computed tomography Þndings of inßuenza A (H1N1) pneumonia in adults: pattern analysis and prognostic comparisons. J Comput Assist Tomogr. 2012;36:285Ð90.
9. Kim SY, Kim JS, Park CS. Various computed tomography Þndings of 2009 H1N1 inßuenza in 17 patients with relatively mild illness. Jpn J Radiol. 2011;29:301Ð6.
10.Marchiori E, Zanetti G, Fontes CA, et al. Inßuenza A (H1N1) virusassociated pneumonia: high-resolution computed tomographypathologic correlation. Eur J Radiol. 2011;80:e500Ð4.
11.Chong S, et al. Adenovirus pneumonia in adults: radiographic and high-resolution CT Þndings in Þve patients. AJR Am J Roentgenol. 2006;186:1288Ð93.
